Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Novel Therapies for Metabolic Complications of Lipodystrophies

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified June 2013 by University of Texas Southwestern Medical Center.
Recruitment status was:  Recruiting
Sponsor:
Collaborators:
National Institutes of Health (NIH)
Takeda
Amylin Pharmaceuticals, LLC.
Information provided by (Responsible Party):
Abhimanyu Garg, University of Texas Southwestern Medical Center
ClinicalTrials.gov Identifier:
NCT00457938
First received: April 4, 2007
Last updated: June 19, 2013
Last verified: June 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2016
  Estimated Primary Completion Date: August 2016 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):